Search

everythinglearnresearchcommunity

for

Search:↓

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Enhancing immune response can improve cancer treatment effectiveness.

A parasite molecule can speed up skin healing and reduce scarring.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

ILC1-like cells can independently cause alopecia areata.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

A fragment of human type XVII collagen shows great potential for skin health and wound healing.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Th22 cells are essential for Tβ15-induced hair growth in mice.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Collagen XVII is crucial for skin cell growth and nail health.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Oleuropein increases IGF-1 levels in mouse skin.